nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—SLC22A5—Niacin—coronary artery disease	0.107	0.19	CbGbCtD
Tiotropium—SLC22A5—Furosemide—coronary artery disease	0.0705	0.125	CbGbCtD
Tiotropium—CYP3A4—Ticagrelor—coronary artery disease	0.0348	0.0617	CbGbCtD
Tiotropium—CYP3A4—Fenofibrate—coronary artery disease	0.031	0.055	CbGbCtD
Tiotropium—CYP2D6—Niacin—coronary artery disease	0.0256	0.0455	CbGbCtD
Tiotropium—CYP3A4—Gemfibrozil—coronary artery disease	0.0248	0.044	CbGbCtD
Tiotropium—CYP2D6—Timolol—coronary artery disease	0.0238	0.0423	CbGbCtD
Tiotropium—CYP3A4—Clopidogrel—coronary artery disease	0.0215	0.0381	CbGbCtD
Tiotropium—CYP2D6—Captopril—coronary artery disease	0.021	0.0372	CbGbCtD
Tiotropium—CYP2D6—Simvastatin—coronary artery disease	0.0203	0.0359	CbGbCtD
Tiotropium—CYP3A4—Eplerenone—coronary artery disease	0.02	0.0355	CbGbCtD
Tiotropium—CYP2D6—Lovastatin—coronary artery disease	0.0198	0.0352	CbGbCtD
Tiotropium—CYP2D6—Pravastatin—coronary artery disease	0.0198	0.0352	CbGbCtD
Tiotropium—CYP2D6—Atorvastatin—coronary artery disease	0.0181	0.032	CbGbCtD
Tiotropium—CYP3A4—Enalapril—coronary artery disease	0.0178	0.0316	CbGbCtD
Tiotropium—CYP3A4—Rosuvastatin—coronary artery disease	0.0139	0.0246	CbGbCtD
Tiotropium—CYP3A4—Ezetimibe—coronary artery disease	0.0139	0.0246	CbGbCtD
Tiotropium—CYP3A4—Simvastatin—coronary artery disease	0.0129	0.0228	CbGbCtD
Tiotropium—CYP3A4—Pravastatin—coronary artery disease	0.0126	0.0224	CbGbCtD
Tiotropium—CYP3A4—Lovastatin—coronary artery disease	0.0126	0.0224	CbGbCtD
Tiotropium—CYP3A4—Atorvastatin—coronary artery disease	0.0115	0.0204	CbGbCtD
Tiotropium—CYP3A4—Losartan—coronary artery disease	0.0105	0.0186	CbGbCtD
Tiotropium—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000156	0.000521	CcSEcCtD
Tiotropium—Constipation—Captopril—coronary artery disease	0.000155	0.000521	CcSEcCtD
Tiotropium—Angioedema—Timolol—coronary artery disease	0.000155	0.00052	CcSEcCtD
Tiotropium—Dyspepsia—Perindopril—coronary artery disease	0.000155	0.00052	CcSEcCtD
Tiotropium—Gastrointestinal pain—Enalapril—coronary artery disease	0.000155	0.000519	CcSEcCtD
Tiotropium—Abdominal pain—Pravastatin—coronary artery disease	0.000155	0.000519	CcSEcCtD
Tiotropium—Dizziness—Clopidogrel—coronary artery disease	0.000154	0.000517	CcSEcCtD
Tiotropium—Paraesthesia—Furosemide—coronary artery disease	0.000154	0.000516	CcSEcCtD
Tiotropium—Palpitations—Ramipril—coronary artery disease	0.000154	0.000515	CcSEcCtD
Tiotropium—Pruritus—Simvastatin—coronary artery disease	0.000153	0.000514	CcSEcCtD
Tiotropium—Dizziness—Lovastatin—coronary artery disease	0.000153	0.000513	CcSEcCtD
Tiotropium—Loss of consciousness—Ramipril—coronary artery disease	0.000153	0.000512	CcSEcCtD
Tiotropium—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000153	0.000512	CcSEcCtD
Tiotropium—Back pain—Lisinopril—coronary artery disease	0.000153	0.000511	CcSEcCtD
Tiotropium—Syncope—Timolol—coronary artery disease	0.000152	0.000511	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000152	0.00051	CcSEcCtD
Tiotropium—Cough—Ramipril—coronary artery disease	0.000152	0.000508	CcSEcCtD
Tiotropium—Urticaria—Trandolapril—coronary artery disease	0.000151	0.000506	CcSEcCtD
Tiotropium—Constipation—Perindopril—coronary artery disease	0.000151	0.000505	CcSEcCtD
Tiotropium—Vomiting—Fenofibrate—coronary artery disease	0.000151	0.000505	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000151	0.000505	CcSEcCtD
Tiotropium—Hypersensitivity—Valsartan—coronary artery disease	0.000151	0.000505	CcSEcCtD
Tiotropium—Urticaria—Enalapril—coronary artery disease	0.000151	0.000504	CcSEcCtD
Tiotropium—Abdominal pain—Trandolapril—coronary artery disease	0.00015	0.000504	CcSEcCtD
Tiotropium—Dizziness—Ezetimibe—coronary artery disease	0.00015	0.000503	CcSEcCtD
Tiotropium—Palpitations—Timolol—coronary artery disease	0.00015	0.000503	CcSEcCtD
Tiotropium—Abdominal pain—Enalapril—coronary artery disease	0.00015	0.000502	CcSEcCtD
Tiotropium—Insomnia—Losartan—coronary artery disease	0.00015	0.000501	CcSEcCtD
Tiotropium—Rash—Fenofibrate—coronary artery disease	0.00015	0.000501	CcSEcCtD
Tiotropium—Dermatitis—Fenofibrate—coronary artery disease	0.000149	0.000501	CcSEcCtD
Tiotropium—Loss of consciousness—Timolol—coronary artery disease	0.000149	0.000501	CcSEcCtD
Tiotropium—Headache—Fenofibrate—coronary artery disease	0.000149	0.000498	CcSEcCtD
Tiotropium—Vision blurred—Lisinopril—coronary artery disease	0.000149	0.000498	CcSEcCtD
Tiotropium—Paraesthesia—Losartan—coronary artery disease	0.000149	0.000498	CcSEcCtD
Tiotropium—Gastrointestinal pain—Captopril—coronary artery disease	0.000149	0.000498	CcSEcCtD
Tiotropium—Urticaria—Telmisartan—coronary artery disease	0.000148	0.000497	CcSEcCtD
Tiotropium—Cough—Timolol—coronary artery disease	0.000148	0.000497	CcSEcCtD
Tiotropium—Vomiting—Clopidogrel—coronary artery disease	0.000148	0.000497	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000148	0.000496	CcSEcCtD
Tiotropium—Chest pain—Ramipril—coronary artery disease	0.000148	0.000496	CcSEcCtD
Tiotropium—Myalgia—Ramipril—coronary artery disease	0.000148	0.000496	CcSEcCtD
Tiotropium—Arthralgia—Ramipril—coronary artery disease	0.000148	0.000496	CcSEcCtD
Tiotropium—Abdominal pain—Telmisartan—coronary artery disease	0.000148	0.000495	CcSEcCtD
Tiotropium—Vomiting—Lovastatin—coronary artery disease	0.000147	0.000493	CcSEcCtD
Tiotropium—Dizziness—Eplerenone—coronary artery disease	0.000147	0.000493	CcSEcCtD
Tiotropium—Rash—Clopidogrel—coronary artery disease	0.000147	0.000493	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000147	0.000493	CcSEcCtD
Tiotropium—Dermatitis—Clopidogrel—coronary artery disease	0.000147	0.000492	CcSEcCtD
Tiotropium—Hypertension—Timolol—coronary artery disease	0.000147	0.000492	CcSEcCtD
Tiotropium—Constipation—Furosemide—coronary artery disease	0.000147	0.000491	CcSEcCtD
Tiotropium—Hypersensitivity—Niacin—coronary artery disease	0.000147	0.000491	CcSEcCtD
Tiotropium—Headache—Clopidogrel—coronary artery disease	0.000146	0.000489	CcSEcCtD
Tiotropium—Rash—Lovastatin—coronary artery disease	0.000146	0.000489	CcSEcCtD
Tiotropium—Dermatitis—Lovastatin—coronary artery disease	0.000146	0.000489	CcSEcCtD
Tiotropium—Dyspepsia—Losartan—coronary artery disease	0.000146	0.000488	CcSEcCtD
Tiotropium—Headache—Lovastatin—coronary artery disease	0.000145	0.000486	CcSEcCtD
Tiotropium—Pruritus—Valsartan—coronary artery disease	0.000145	0.000485	CcSEcCtD
Tiotropium—Dry mouth—Ramipril—coronary artery disease	0.000145	0.000485	CcSEcCtD
Tiotropium—Chest pain—Timolol—coronary artery disease	0.000145	0.000485	CcSEcCtD
Tiotropium—Arthralgia—Timolol—coronary artery disease	0.000145	0.000485	CcSEcCtD
Tiotropium—Myalgia—Timolol—coronary artery disease	0.000145	0.000485	CcSEcCtD
Tiotropium—Vomiting—Ezetimibe—coronary artery disease	0.000144	0.000484	CcSEcCtD
Tiotropium—Hypersensitivity—Pravastatin—coronary artery disease	0.000144	0.000484	CcSEcCtD
Tiotropium—Gastrointestinal pain—Perindopril—coronary artery disease	0.000144	0.000483	CcSEcCtD
Tiotropium—Angioedema—Lisinopril—coronary artery disease	0.000144	0.000483	CcSEcCtD
Tiotropium—Pruritus—Olmesartan—coronary artery disease	0.000144	0.000483	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000144	0.000481	CcSEcCtD
Tiotropium—Abdominal pain—Captopril—coronary artery disease	0.000144	0.000481	CcSEcCtD
Tiotropium—Dizziness—Simvastatin—coronary artery disease	0.000143	0.00048	CcSEcCtD
Tiotropium—Rash—Ezetimibe—coronary artery disease	0.000143	0.00048	CcSEcCtD
Tiotropium—Dermatitis—Ezetimibe—coronary artery disease	0.000143	0.00048	CcSEcCtD
Tiotropium—Headache—Ezetimibe—coronary artery disease	0.000142	0.000477	CcSEcCtD
Tiotropium—Oedema—Ramipril—coronary artery disease	0.000142	0.000475	CcSEcCtD
Tiotropium—Dry mouth—Timolol—coronary artery disease	0.000142	0.000474	CcSEcCtD
Tiotropium—Constipation—Losartan—coronary artery disease	0.000142	0.000474	CcSEcCtD
Tiotropium—Syncope—Lisinopril—coronary artery disease	0.000141	0.000474	CcSEcCtD
Tiotropium—Vomiting—Eplerenone—coronary artery disease	0.000141	0.000474	CcSEcCtD
Tiotropium—Nausea—Fenofibrate—coronary artery disease	0.000141	0.000472	CcSEcCtD
Tiotropium—Pruritus—Niacin—coronary artery disease	0.000141	0.000472	CcSEcCtD
Tiotropium—Gastrointestinal pain—Furosemide—coronary artery disease	0.00014	0.00047	CcSEcCtD
Tiotropium—Rash—Eplerenone—coronary artery disease	0.00014	0.00047	CcSEcCtD
Tiotropium—Urticaria—Perindopril—coronary artery disease	0.00014	0.00047	CcSEcCtD
Tiotropium—Hypersensitivity—Trandolapril—coronary artery disease	0.00014	0.00047	CcSEcCtD
Tiotropium—Dermatitis—Eplerenone—coronary artery disease	0.00014	0.000469	CcSEcCtD
Tiotropium—Shock—Ramipril—coronary artery disease	0.00014	0.000468	CcSEcCtD
Tiotropium—Hypersensitivity—Enalapril—coronary artery disease	0.00014	0.000468	CcSEcCtD
Tiotropium—Abdominal pain—Perindopril—coronary artery disease	0.000139	0.000467	CcSEcCtD
Tiotropium—Palpitations—Lisinopril—coronary artery disease	0.000139	0.000467	CcSEcCtD
Tiotropium—Headache—Eplerenone—coronary artery disease	0.000139	0.000467	CcSEcCtD
Tiotropium—Nervous system disorder—Ramipril—coronary artery disease	0.000139	0.000466	CcSEcCtD
Tiotropium—Oedema—Timolol—coronary artery disease	0.000139	0.000465	CcSEcCtD
Tiotropium—Pruritus—Pravastatin—coronary artery disease	0.000139	0.000464	CcSEcCtD
Tiotropium—Loss of consciousness—Lisinopril—coronary artery disease	0.000139	0.000464	CcSEcCtD
Tiotropium—Nausea—Clopidogrel—coronary artery disease	0.000139	0.000464	CcSEcCtD
Tiotropium—Tachycardia—Ramipril—coronary artery disease	0.000139	0.000464	CcSEcCtD
Tiotropium—Skin disorder—Ramipril—coronary artery disease	0.000138	0.000462	CcSEcCtD
Tiotropium—Infection—Timolol—coronary artery disease	0.000138	0.000462	CcSEcCtD
Tiotropium—Vomiting—Simvastatin—coronary artery disease	0.000138	0.000462	CcSEcCtD
Tiotropium—Hypersensitivity—Telmisartan—coronary artery disease	0.000138	0.000461	CcSEcCtD
Tiotropium—Cough—Lisinopril—coronary artery disease	0.000138	0.000461	CcSEcCtD
Tiotropium—Nausea—Lovastatin—coronary artery disease	0.000138	0.000461	CcSEcCtD
Tiotropium—Rash—Simvastatin—coronary artery disease	0.000137	0.000458	CcSEcCtD
Tiotropium—Dermatitis—Simvastatin—coronary artery disease	0.000137	0.000457	CcSEcCtD
Tiotropium—Shock—Timolol—coronary artery disease	0.000136	0.000457	CcSEcCtD
Tiotropium—Urticaria—Furosemide—coronary artery disease	0.000136	0.000457	CcSEcCtD
Tiotropium—Nervous system disorder—Timolol—coronary artery disease	0.000136	0.000456	CcSEcCtD
Tiotropium—Headache—Simvastatin—coronary artery disease	0.000136	0.000455	CcSEcCtD
Tiotropium—Abdominal pain—Furosemide—coronary artery disease	0.000136	0.000454	CcSEcCtD
Tiotropium—Gastrointestinal pain—Losartan—coronary artery disease	0.000135	0.000453	CcSEcCtD
Tiotropium—Dizziness—Valsartan—coronary artery disease	0.000135	0.000453	CcSEcCtD
Tiotropium—Nausea—Ezetimibe—coronary artery disease	0.000135	0.000452	CcSEcCtD
Tiotropium—Skin disorder—Timolol—coronary artery disease	0.000135	0.000451	CcSEcCtD
Tiotropium—Dizziness—Olmesartan—coronary artery disease	0.000135	0.000451	CcSEcCtD
Tiotropium—Pruritus—Trandolapril—coronary artery disease	0.000135	0.000451	CcSEcCtD
Tiotropium—Chest pain—Lisinopril—coronary artery disease	0.000134	0.00045	CcSEcCtD
Tiotropium—Arthralgia—Lisinopril—coronary artery disease	0.000134	0.00045	CcSEcCtD
Tiotropium—Myalgia—Lisinopril—coronary artery disease	0.000134	0.00045	CcSEcCtD
Tiotropium—Pruritus—Enalapril—coronary artery disease	0.000134	0.000449	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000133	0.000447	CcSEcCtD
Tiotropium—Pruritus—Telmisartan—coronary artery disease	0.000132	0.000443	CcSEcCtD
Tiotropium—Nausea—Eplerenone—coronary artery disease	0.000132	0.000443	CcSEcCtD
Tiotropium—Dizziness—Niacin—coronary artery disease	0.000132	0.000441	CcSEcCtD
Tiotropium—Urticaria—Losartan—coronary artery disease	0.000131	0.00044	CcSEcCtD
Tiotropium—Dry mouth—Lisinopril—coronary artery disease	0.000131	0.00044	CcSEcCtD
Tiotropium—Abdominal pain—Losartan—coronary artery disease	0.000131	0.000438	CcSEcCtD
Tiotropium—Vomiting—Valsartan—coronary artery disease	0.00013	0.000436	CcSEcCtD
Tiotropium—Dizziness—Pravastatin—coronary artery disease	0.00013	0.000434	CcSEcCtD
Tiotropium—Vomiting—Olmesartan—coronary artery disease	0.000129	0.000434	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000129	0.000433	CcSEcCtD
Tiotropium—Rash—Valsartan—coronary artery disease	0.000129	0.000432	CcSEcCtD
Tiotropium—Dermatitis—Valsartan—coronary artery disease	0.000129	0.000432	CcSEcCtD
Tiotropium—Nausea—Simvastatin—coronary artery disease	0.000129	0.000431	CcSEcCtD
Tiotropium—Oedema—Lisinopril—coronary artery disease	0.000129	0.000431	CcSEcCtD
Tiotropium—Pruritus—Captopril—coronary artery disease	0.000129	0.000431	CcSEcCtD
Tiotropium—Rash—Olmesartan—coronary artery disease	0.000128	0.00043	CcSEcCtD
Tiotropium—Insomnia—Ramipril—coronary artery disease	0.000128	0.00043	CcSEcCtD
Tiotropium—Dermatitis—Olmesartan—coronary artery disease	0.000128	0.00043	CcSEcCtD
Tiotropium—Headache—Valsartan—coronary artery disease	0.000128	0.000429	CcSEcCtD
Tiotropium—Infection—Lisinopril—coronary artery disease	0.000128	0.000428	CcSEcCtD
Tiotropium—Headache—Olmesartan—coronary artery disease	0.000128	0.000427	CcSEcCtD
Tiotropium—Paraesthesia—Ramipril—coronary artery disease	0.000127	0.000427	CcSEcCtD
Tiotropium—Shock—Lisinopril—coronary artery disease	0.000127	0.000424	CcSEcCtD
Tiotropium—Vomiting—Niacin—coronary artery disease	0.000127	0.000424	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000126	0.000423	CcSEcCtD
Tiotropium—Hypersensitivity—Furosemide—coronary artery disease	0.000126	0.000423	CcSEcCtD
Tiotropium—Dizziness—Trandolapril—coronary artery disease	0.000126	0.000421	CcSEcCtD
Tiotropium—Tachycardia—Lisinopril—coronary artery disease	0.000126	0.000421	CcSEcCtD
Tiotropium—Insomnia—Timolol—coronary artery disease	0.000125	0.00042	CcSEcCtD
Tiotropium—Rash—Niacin—coronary artery disease	0.000125	0.00042	CcSEcCtD
Tiotropium—Dermatitis—Niacin—coronary artery disease	0.000125	0.00042	CcSEcCtD
Tiotropium—Dizziness—Enalapril—coronary artery disease	0.000125	0.00042	CcSEcCtD
Tiotropium—Skin disorder—Lisinopril—coronary artery disease	0.000125	0.000419	CcSEcCtD
Tiotropium—Dyspepsia—Ramipril—coronary artery disease	0.000125	0.000418	CcSEcCtD
Tiotropium—Pruritus—Perindopril—coronary artery disease	0.000125	0.000418	CcSEcCtD
Tiotropium—Headache—Niacin—coronary artery disease	0.000125	0.000418	CcSEcCtD
Tiotropium—Paraesthesia—Timolol—coronary artery disease	0.000125	0.000417	CcSEcCtD
Tiotropium—Vomiting—Pravastatin—coronary artery disease	0.000125	0.000417	CcSEcCtD
Tiotropium—Dizziness—Telmisartan—coronary artery disease	0.000124	0.000414	CcSEcCtD
Tiotropium—Rash—Pravastatin—coronary artery disease	0.000124	0.000414	CcSEcCtD
Tiotropium—Dermatitis—Pravastatin—coronary artery disease	0.000123	0.000413	CcSEcCtD
Tiotropium—Headache—Pravastatin—coronary artery disease	0.000123	0.000411	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000123	0.00041	CcSEcCtD
Tiotropium—Dyspepsia—Timolol—coronary artery disease	0.000122	0.000409	CcSEcCtD
Tiotropium—Hypersensitivity—Losartan—coronary artery disease	0.000122	0.000408	CcSEcCtD
Tiotropium—Nausea—Valsartan—coronary artery disease	0.000122	0.000407	CcSEcCtD
Tiotropium—Pruritus—Furosemide—coronary artery disease	0.000121	0.000407	CcSEcCtD
Tiotropium—Constipation—Ramipril—coronary artery disease	0.000121	0.000407	CcSEcCtD
Tiotropium—Nausea—Olmesartan—coronary artery disease	0.000121	0.000405	CcSEcCtD
Tiotropium—Vomiting—Trandolapril—coronary artery disease	0.000121	0.000405	CcSEcCtD
Tiotropium—Vomiting—Enalapril—coronary artery disease	0.00012	0.000404	CcSEcCtD
Tiotropium—Dizziness—Captopril—coronary artery disease	0.00012	0.000403	CcSEcCtD
Tiotropium—Rash—Trandolapril—coronary artery disease	0.00012	0.000402	CcSEcCtD
Tiotropium—Dermatitis—Trandolapril—coronary artery disease	0.00012	0.000401	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Timolol—coronary artery disease	0.00012	0.000401	CcSEcCtD
Tiotropium—Rash—Enalapril—coronary artery disease	0.000119	0.0004	CcSEcCtD
Tiotropium—Dermatitis—Enalapril—coronary artery disease	0.000119	0.0004	CcSEcCtD
Tiotropium—Headache—Trandolapril—coronary artery disease	0.000119	0.000399	CcSEcCtD
Tiotropium—Vomiting—Telmisartan—coronary artery disease	0.000119	0.000398	CcSEcCtD
Tiotropium—Headache—Enalapril—coronary artery disease	0.000119	0.000398	CcSEcCtD
Tiotropium—Nausea—Niacin—coronary artery disease	0.000118	0.000396	CcSEcCtD
Tiotropium—Rash—Telmisartan—coronary artery disease	0.000118	0.000395	CcSEcCtD
Tiotropium—Dermatitis—Telmisartan—coronary artery disease	0.000118	0.000394	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000117	0.000393	CcSEcCtD
Tiotropium—Pruritus—Losartan—coronary artery disease	0.000117	0.000392	CcSEcCtD
Tiotropium—Headache—Telmisartan—coronary artery disease	0.000117	0.000392	CcSEcCtD
Tiotropium—Dizziness—Perindopril—coronary artery disease	0.000117	0.000391	CcSEcCtD
Tiotropium—Insomnia—Lisinopril—coronary artery disease	0.000116	0.00039	CcSEcCtD
Tiotropium—Nausea—Pravastatin—coronary artery disease	0.000116	0.00039	CcSEcCtD
Tiotropium—Gastrointestinal pain—Ramipril—coronary artery disease	0.000116	0.000389	CcSEcCtD
Tiotropium—Paraesthesia—Lisinopril—coronary artery disease	0.000116	0.000387	CcSEcCtD
Tiotropium—Vomiting—Captopril—coronary artery disease	0.000116	0.000387	CcSEcCtD
Tiotropium—Rash—Captopril—coronary artery disease	0.000115	0.000384	CcSEcCtD
Tiotropium—Dermatitis—Captopril—coronary artery disease	0.000114	0.000384	CcSEcCtD
Tiotropium—Headache—Captopril—coronary artery disease	0.000114	0.000381	CcSEcCtD
Tiotropium—Gastrointestinal pain—Timolol—coronary artery disease	0.000113	0.00038	CcSEcCtD
Tiotropium—Dizziness—Furosemide—coronary artery disease	0.000113	0.00038	CcSEcCtD
Tiotropium—Dyspepsia—Lisinopril—coronary artery disease	0.000113	0.00038	CcSEcCtD
Tiotropium—Nausea—Trandolapril—coronary artery disease	0.000113	0.000379	CcSEcCtD
Tiotropium—Urticaria—Ramipril—coronary artery disease	0.000113	0.000378	CcSEcCtD
Tiotropium—Nausea—Enalapril—coronary artery disease	0.000113	0.000377	CcSEcCtD
Tiotropium—Vomiting—Perindopril—coronary artery disease	0.000112	0.000376	CcSEcCtD
Tiotropium—Abdominal pain—Ramipril—coronary artery disease	0.000112	0.000376	CcSEcCtD
Tiotropium—Rash—Perindopril—coronary artery disease	0.000111	0.000373	CcSEcCtD
Tiotropium—Dermatitis—Perindopril—coronary artery disease	0.000111	0.000372	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000111	0.000372	CcSEcCtD
Tiotropium—Nausea—Telmisartan—coronary artery disease	0.000111	0.000372	CcSEcCtD
Tiotropium—Headache—Perindopril—coronary artery disease	0.000111	0.00037	CcSEcCtD
Tiotropium—Urticaria—Timolol—coronary artery disease	0.00011	0.000369	CcSEcCtD
Tiotropium—Constipation—Lisinopril—coronary artery disease	0.00011	0.000369	CcSEcCtD
Tiotropium—Abdominal pain—Timolol—coronary artery disease	0.00011	0.000367	CcSEcCtD
Tiotropium—Dizziness—Losartan—coronary artery disease	0.000109	0.000367	CcSEcCtD
Tiotropium—Vomiting—Furosemide—coronary artery disease	0.000109	0.000365	CcSEcCtD
Tiotropium—Rash—Furosemide—coronary artery disease	0.000108	0.000362	CcSEcCtD
Tiotropium—Dermatitis—Furosemide—coronary artery disease	0.000108	0.000362	CcSEcCtD
Tiotropium—Nausea—Captopril—coronary artery disease	0.000108	0.000362	CcSEcCtD
Tiotropium—Headache—Furosemide—coronary artery disease	0.000107	0.00036	CcSEcCtD
Tiotropium—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000105	0.000353	CcSEcCtD
Tiotropium—Vomiting—Losartan—coronary artery disease	0.000105	0.000353	CcSEcCtD
Tiotropium—Nausea—Perindopril—coronary artery disease	0.000105	0.000351	CcSEcCtD
Tiotropium—Hypersensitivity—Ramipril—coronary artery disease	0.000105	0.00035	CcSEcCtD
Tiotropium—Rash—Losartan—coronary artery disease	0.000104	0.00035	CcSEcCtD
Tiotropium—Dermatitis—Losartan—coronary artery disease	0.000104	0.000349	CcSEcCtD
Tiotropium—Headache—Losartan—coronary artery disease	0.000104	0.000347	CcSEcCtD
Tiotropium—Urticaria—Lisinopril—coronary artery disease	0.000102	0.000343	CcSEcCtD
Tiotropium—Hypersensitivity—Timolol—coronary artery disease	0.000102	0.000342	CcSEcCtD
Tiotropium—Nausea—Furosemide—coronary artery disease	0.000102	0.000341	CcSEcCtD
Tiotropium—Abdominal pain—Lisinopril—coronary artery disease	0.000102	0.000341	CcSEcCtD
Tiotropium—Pruritus—Ramipril—coronary artery disease	0.0001	0.000336	CcSEcCtD
Tiotropium—Nausea—Losartan—coronary artery disease	9.83e-05	0.000329	CcSEcCtD
Tiotropium—Pruritus—Timolol—coronary artery disease	9.82e-05	0.000329	CcSEcCtD
Tiotropium—Hypersensitivity—Lisinopril—coronary artery disease	9.48e-05	0.000318	CcSEcCtD
Tiotropium—Dizziness—Ramipril—coronary artery disease	9.38e-05	0.000314	CcSEcCtD
Tiotropium—Dizziness—Timolol—coronary artery disease	9.17e-05	0.000307	CcSEcCtD
Tiotropium—Pruritus—Lisinopril—coronary artery disease	9.11e-05	0.000305	CcSEcCtD
Tiotropium—Vomiting—Ramipril—coronary artery disease	9.02e-05	0.000302	CcSEcCtD
Tiotropium—Rash—Ramipril—coronary artery disease	8.95e-05	0.0003	CcSEcCtD
Tiotropium—Dermatitis—Ramipril—coronary artery disease	8.94e-05	0.000299	CcSEcCtD
Tiotropium—Headache—Ramipril—coronary artery disease	8.89e-05	0.000298	CcSEcCtD
Tiotropium—Vomiting—Timolol—coronary artery disease	8.82e-05	0.000296	CcSEcCtD
Tiotropium—Rash—Timolol—coronary artery disease	8.75e-05	0.000293	CcSEcCtD
Tiotropium—Dermatitis—Timolol—coronary artery disease	8.74e-05	0.000293	CcSEcCtD
Tiotropium—Headache—Timolol—coronary artery disease	8.69e-05	0.000291	CcSEcCtD
Tiotropium—Dizziness—Lisinopril—coronary artery disease	8.51e-05	0.000285	CcSEcCtD
Tiotropium—Nausea—Ramipril—coronary artery disease	8.43e-05	0.000282	CcSEcCtD
Tiotropium—Nausea—Timolol—coronary artery disease	8.24e-05	0.000276	CcSEcCtD
Tiotropium—Vomiting—Lisinopril—coronary artery disease	8.18e-05	0.000274	CcSEcCtD
Tiotropium—Rash—Lisinopril—coronary artery disease	8.11e-05	0.000272	CcSEcCtD
Tiotropium—Dermatitis—Lisinopril—coronary artery disease	8.11e-05	0.000272	CcSEcCtD
Tiotropium—Headache—Lisinopril—coronary artery disease	8.06e-05	0.00027	CcSEcCtD
Tiotropium—Nausea—Lisinopril—coronary artery disease	7.64e-05	0.000256	CcSEcCtD
Tiotropium—CHRM2—Signaling Pathways—CSF2—coronary artery disease	7.55e-06	5.48e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FGF1—coronary artery disease	7.55e-06	5.48e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	7.52e-06	5.46e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	7.52e-06	5.46e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	7.5e-06	5.44e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	7.5e-06	5.44e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—APOA1—coronary artery disease	7.49e-06	5.44e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LPL—coronary artery disease	7.49e-06	5.44e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF1—coronary artery disease	7.46e-06	5.42e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HADHA—coronary artery disease	7.46e-06	5.42e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—MAPK1—coronary artery disease	7.43e-06	5.39e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	7.42e-06	5.39e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	7.42e-06	5.39e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTA1—coronary artery disease	7.38e-06	5.36e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	7.33e-06	5.32e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	7.3e-06	5.3e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LPA—coronary artery disease	7.29e-06	5.3e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	7.23e-06	5.25e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	7.15e-06	5.19e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	7.13e-06	5.18e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	7.12e-06	5.17e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PLCB1—coronary artery disease	7.11e-06	5.16e-05	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—PIK3CA—coronary artery disease	7.1e-06	5.15e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	7.1e-06	5.15e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SERPINE1—coronary artery disease	7.09e-06	5.15e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PLCB3—coronary artery disease	7.06e-06	5.13e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	7.06e-06	5.13e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	7.03e-06	5.1e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOA5—coronary artery disease	6.99e-06	5.08e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	6.99e-06	5.08e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	6.97e-06	5.06e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	6.9e-06	5.01e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ABCA1—coronary artery disease	6.89e-06	5e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—FGF2—coronary artery disease	6.86e-06	4.98e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—P4HB—coronary artery disease	6.86e-06	4.98e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	6.84e-06	4.97e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—C3—coronary artery disease	6.83e-06	4.96e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	6.82e-06	4.95e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—C3—coronary artery disease	6.81e-06	4.94e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOS3—coronary artery disease	6.77e-06	4.91e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	6.75e-06	4.9e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—C3—coronary artery disease	6.74e-06	4.9e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	6.73e-06	4.89e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GGT1—coronary artery disease	6.68e-06	4.85e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GOT1—coronary artery disease	6.68e-06	4.85e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARG—coronary artery disease	6.6e-06	4.79e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—JAK2—coronary artery disease	6.58e-06	4.77e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	6.52e-06	4.73e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—POMC—coronary artery disease	6.51e-06	4.73e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	6.49e-06	4.71e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AGT—coronary artery disease	6.49e-06	4.71e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AGT—coronary artery disease	6.47e-06	4.7e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—PIK3CA—coronary artery disease	6.45e-06	4.68e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	6.43e-06	4.67e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AGT—coronary artery disease	6.41e-06	4.65e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOE—coronary artery disease	6.36e-06	4.62e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LEP—coronary artery disease	6.36e-06	4.62e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—VCAN—coronary artery disease	6.35e-06	4.61e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LEP—coronary artery disease	6.34e-06	4.6e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOE—coronary artery disease	6.34e-06	4.6e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALDOA—coronary artery disease	6.3e-06	4.57e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOA1—coronary artery disease	6.29e-06	4.56e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LEP—coronary artery disease	6.28e-06	4.56e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOE—coronary artery disease	6.28e-06	4.56e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOA1—coronary artery disease	6.27e-06	4.55e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KDR—coronary artery disease	6.23e-06	4.52e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KDR—coronary artery disease	6.21e-06	4.51e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOA1—coronary artery disease	6.21e-06	4.51e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	6.19e-06	4.49e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	6.17e-06	4.48e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KDR—coronary artery disease	6.15e-06	4.47e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—DCN—coronary artery disease	6.11e-06	4.44e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	6.11e-06	4.44e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ESR1—coronary artery disease	6.07e-06	4.41e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ESR1—coronary artery disease	6.05e-06	4.39e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	6e-06	4.36e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FN1—coronary artery disease	6e-06	4.35e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—F2—coronary artery disease	6e-06	4.35e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTP1—coronary artery disease	6e-06	4.35e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ESR1—coronary artery disease	5.99e-06	4.35e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—F2—coronary artery disease	5.98e-06	4.34e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FN1—coronary artery disease	5.98e-06	4.34e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	5.97e-06	4.34e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	5.95e-06	4.32e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALDH2—coronary artery disease	5.95e-06	4.32e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	5.94e-06	4.31e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALB—coronary artery disease	5.94e-06	4.31e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	5.93e-06	4.3e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—F2—coronary artery disease	5.92e-06	4.3e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FN1—coronary artery disease	5.92e-06	4.3e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMOX1—coronary artery disease	5.91e-06	4.29e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	5.91e-06	4.29e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	5.9e-06	4.28e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	5.85e-06	4.25e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CAT—coronary artery disease	5.83e-06	4.24e-05	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	5.8e-06	4.21e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LIPC—coronary artery disease	5.79e-06	4.21e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HBA1—coronary artery disease	5.79e-06	4.21e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	5.79e-06	4.21e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP2C19—coronary artery disease	5.79e-06	4.21e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOC3—coronary artery disease	5.76e-06	4.18e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CASP3—coronary artery disease	5.75e-06	4.17e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KIT—coronary artery disease	5.74e-06	4.17e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LDLR—coronary artery disease	5.72e-06	4.16e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KIT—coronary artery disease	5.72e-06	4.15e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—coronary artery disease	5.71e-06	4.14e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—NOS3—coronary artery disease	5.68e-06	4.12e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KIT—coronary artery disease	5.67e-06	4.11e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOB—coronary artery disease	5.66e-06	4.11e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC9A1—coronary artery disease	5.66e-06	4.11e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTT1—coronary artery disease	5.66e-06	4.11e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCND1—coronary artery disease	5.59e-06	4.06e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GCLC—coronary artery disease	5.59e-06	4.06e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CETP—coronary artery disease	5.59e-06	4.06e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SDC1—coronary artery disease	5.53e-06	4.01e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTM1—coronary artery disease	5.51e-06	4e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	5.51e-06	4e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	5.49e-06	3.99e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—POMC—coronary artery disease	5.46e-06	3.97e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CREB1—coronary artery disease	5.46e-06	3.97e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—POMC—coronary artery disease	5.45e-06	3.95e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CREB1—coronary artery disease	5.45e-06	3.95e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	5.44e-06	3.95e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MMP9—coronary artery disease	5.43e-06	3.94e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—LPL—coronary artery disease	5.41e-06	3.93e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—POMC—coronary artery disease	5.39e-06	3.92e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CREB1—coronary artery disease	5.39e-06	3.92e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCL2—coronary artery disease	5.35e-06	3.88e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6R—coronary artery disease	5.33e-06	3.87e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCL2—coronary artery disease	5.33e-06	3.87e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6R—coronary artery disease	5.31e-06	3.86e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCL2—coronary artery disease	5.28e-06	3.83e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GPX1—coronary artery disease	5.28e-06	3.83e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	5.27e-06	3.82e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6R—coronary artery disease	5.26e-06	3.82e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF1—coronary artery disease	5.26e-06	3.82e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF1—coronary artery disease	5.24e-06	3.8e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	5.23e-06	3.8e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSMB5—coronary artery disease	5.22e-06	3.79e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSMA6—coronary artery disease	5.22e-06	3.79e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	5.21e-06	3.79e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS2—coronary artery disease	5.2e-06	3.77e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF1—coronary artery disease	5.19e-06	3.77e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	5.16e-06	3.75e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CD36—coronary artery disease	5.14e-06	3.73e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CTGF—coronary artery disease	5.1e-06	3.7e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPP2CA—coronary artery disease	5.07e-06	3.68e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMGCR—coronary artery disease	5.06e-06	3.67e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GOT2—coronary artery disease	5.06e-06	3.67e-05	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	5e-06	3.63e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	4.99e-06	3.62e-05	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	4.98e-06	3.62e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	4.97e-06	3.61e-05	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.93e-06	3.58e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	4.93e-06	3.58e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	4.88e-06	3.54e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MTHFR—coronary artery disease	4.87e-06	3.54e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FGF2—coronary artery disease	4.83e-06	3.51e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FGF2—coronary artery disease	4.82e-06	3.5e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FGF2—coronary artery disease	4.77e-06	3.46e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOS3—coronary artery disease	4.76e-06	3.46e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOS3—coronary artery disease	4.75e-06	3.45e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOS3—coronary artery disease	4.7e-06	3.41e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PLCB1—coronary artery disease	4.65e-06	3.38e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—JAK2—coronary artery disease	4.63e-06	3.36e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AGT—coronary artery disease	4.63e-06	3.36e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—JAK2—coronary artery disease	4.62e-06	3.35e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—JAK2—coronary artery disease	4.57e-06	3.32e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	4.54e-06	3.3e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOE—coronary artery disease	4.53e-06	3.29e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	4.52e-06	3.28e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ABCA1—coronary artery disease	4.51e-06	3.27e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOA1—coronary artery disease	4.48e-06	3.25e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	4.48e-06	3.25e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	4.47e-06	3.25e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	4.39e-06	3.19e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GOT1—coronary artery disease	4.36e-06	3.17e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GGT1—coronary artery disease	4.36e-06	3.17e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	4.23e-06	3.07e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	4.21e-06	3.06e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	4.17e-06	3.03e-05	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	4.08e-06	2.96e-05	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	4.07e-06	2.95e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CASP3—coronary artery disease	4.05e-06	2.94e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CASP3—coronary artery disease	4.03e-06	2.93e-05	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	4.03e-06	2.93e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—coronary artery disease	4.02e-06	2.92e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—coronary artery disease	4.01e-06	2.91e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CASP3—coronary artery disease	3.99e-06	2.9e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6—coronary artery disease	3.97e-06	2.88e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARG—coronary artery disease	3.95e-06	2.87e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCND1—coronary artery disease	3.94e-06	2.86e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCND1—coronary artery disease	3.92e-06	2.85e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.92e-06	2.85e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—POMC—coronary artery disease	3.89e-06	2.83e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCND1—coronary artery disease	3.89e-06	2.82e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.88e-06	2.82e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.87e-06	2.81e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MMP9—coronary artery disease	3.82e-06	2.78e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CAT—coronary artery disease	3.81e-06	2.77e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MMP9—coronary artery disease	3.81e-06	2.77e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	3.81e-06	2.76e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP9—coronary artery disease	3.77e-06	2.74e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	3.71e-06	2.69e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOB—coronary artery disease	3.7e-06	2.69e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	3.7e-06	2.68e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	3.66e-06	2.66e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.6e-06	2.62e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALB—coronary artery disease	3.55e-06	2.58e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LPL—coronary artery disease	3.54e-06	2.57e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPX1—coronary artery disease	3.45e-06	2.5e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	3.43e-06	2.49e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	3.42e-06	2.48e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—NOS3—coronary artery disease	3.4e-06	2.47e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	3.39e-06	2.46e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—coronary artery disease	3.37e-06	2.45e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CD36—coronary artery disease	3.36e-06	2.44e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.32e-06	2.41e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CA—coronary artery disease	3.2e-06	2.32e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.18e-06	2.31e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	3.15e-06	2.29e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	3.14e-06	2.28e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKT1—coronary artery disease	3.11e-06	2.26e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	3.11e-06	2.26e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.11e-06	2.26e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	3.09e-06	2.24e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	3.08e-06	2.24e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	3.05e-06	2.21e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AGT—coronary artery disease	3.03e-06	2.2e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOE—coronary artery disease	2.96e-06	2.15e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOA1—coronary artery disease	2.93e-06	2.13e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.68e-06	1.95e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	2.67e-06	1.94e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	2.65e-06	1.92e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AKT1—coronary artery disease	2.61e-06	1.9e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARG—coronary artery disease	2.58e-06	1.87e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—POMC—coronary artery disease	2.55e-06	1.85e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—coronary artery disease	2.37e-06	1.72e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—coronary artery disease	2.37e-06	1.72e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—coronary artery disease	2.34e-06	1.7e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALB—coronary artery disease	2.32e-06	1.69e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NOS3—coronary artery disease	2.22e-06	1.61e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKT1—coronary artery disease	2.19e-06	1.59e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKT1—coronary artery disease	2.18e-06	1.59e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKT1—coronary artery disease	2.16e-06	1.57e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.03e-06	1.47e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.91e-06	1.39e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AKT1—coronary artery disease	1.56e-06	1.13e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.25e-06	9.07e-06	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AKT1—coronary artery disease	1.02e-06	7.41e-06	CbGpPWpGaD
